ARTICLE | Top Story
Cholesterol absorption inhibitor data
May 21, 2001 7:00 AM UTC
Merck (MRK) and partner Schering-Plough (SGP) said data from a Phase III study in 827 hypercholesterolemia patients showed an 18% reduction in low-density lipoprotein cholesterol (LDL-C) in patients r...